Screener
Schrodinger SDGR Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$58.9MBeat by $11.7M
EPS$0.08Beat by $0.49
Revenue estimate$47.2M
EPS estimate-$0.41
“As biopharma navigates a rapidly evolving AI landscape and mounting pressure to optimize and accelerate the discovery of new medicines, the need to generate ground-truth data has never been greater. By integrating our highly accurate, physics-based simulations with AI, and launching our agentic co-scientist Bunsen, we are enabling teams to execute complex workflows on a large scale and building the definitive computational infrastructure for the future of drug discovery.”
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$48.6M
EPS estimate-$0.66
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Schrodinger report Q2 2026 earnings?
- Schrodinger (SDGR) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were Schrodinger's Q2 2026 revenue and EPS?
- Schrodinger reported revenue of $58.9M and eps of $0.08 for Q2 2026.
- Did Schrodinger beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $47.2M by $11.7M. EPS beat the consensus estimate of $-0.41 by $0.49.
- How did Schrodinger's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 7.5% from $54.8M a year earlier.
- Where can I find Schrodinger's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001490978-26-000067) and the 10-Q periodic report (0001490978-26-000068) directly on SEC EDGAR. The filing index links above go to sec.gov.
